These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30590105)

  • 21. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
    Marchetti B
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endurance Exercise Mediates Neuroprotection Against MPTP-mediated Parkinson's Disease via Enhanced Neurogenesis, Antioxidant Capacity, and Autophagy.
    Jang Y; Kwon I; Song W; Cosio-Lima LM; Lee Y
    Neuroscience; 2018 May; 379():292-301. PubMed ID: 29559387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
    Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
    Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
    Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
    FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
    Choi DY; Lee MK; Hong JT
    Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent Expression Patterns of Drp1 and HSD10 in the Nigro-Striatum of Two Mice Strains Based on their MPTP Susceptibility.
    Seshadri A; Alladi PA
    Neurotox Res; 2019 Jul; 36(1):27-38. PubMed ID: 30993548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-Caryophyllene exerts protective antioxidant effects through the activation of NQO1 in the MPTP model of Parkinson's disease.
    Flores-Soto ME; Corona-Angeles JA; Tejeda-Martinez AR; Flores-Guzman PA; Luna-Mujica I; Chaparro-Huerta V; Viveros-Paredes JM
    Neurosci Lett; 2021 Jan; 742():135534. PubMed ID: 33271195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ghrelin protects dopaminergic neurons against MPTP neurotoxicity through promoting autophagy and inhibiting endoplasmic reticulum mediated apoptosis.
    Wang H; Dou S; Zhu J; Shao Z; Wang C; Cheng B
    Brain Res; 2020 Nov; 1746():147023. PubMed ID: 32710901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of Nur77 in microglia attenuates proinflammatory mediators production and protects dopaminergic neurons from inflammation-induced cell death.
    Liu TY; Yang XY; Zheng LT; Wang GH; Zhen XC
    J Neurochem; 2017 Feb; 140(4):589-604. PubMed ID: 27889907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
    Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
    Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.
    Vivacqua G; Biagioni F; Yu S; Casini A; Bucci D; D'Este L; Fornai F
    J Chem Neuroanat; 2012 Jul; 44(2):76-85. PubMed ID: 22580273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphatidylinositol 3-kinase/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson's disease.
    Kim SN; Kim ST; Doo AR; Park JY; Moon W; Chae Y; Yin CS; Lee H; Park HJ
    Int J Neurosci; 2011 Oct; 121(10):562-9. PubMed ID: 21770712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
    Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
    Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic Upregulation of Glial Lipocalin-2 in the Parkinsonian Dopaminergic System.
    Kim BW; Jeong KH; Kim JH; Jin M; Kim JH; Lee MG; Choi DK; Won SY; McLean C; Jeon MT; Lee HW; Kim SR; Suk K
    J Neurosci; 2016 May; 36(20):5608-22. PubMed ID: 27194339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
    Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
    Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
    Lofrumento DD; Nicolardi G; Cianciulli A; De Nuccio F; La Pesa V; Carofiglio V; Dragone T; Calvello R; Panaro MA
    Innate Immun; 2014 Apr; 20(3):249-60. PubMed ID: 23764428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease.
    Zheng M; Liu C; Fan Y; Yan P; Shi D; Zhang Y
    Neuropharmacology; 2017 Apr; 116():412-420. PubMed ID: 28093210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.